Measuring and Improving Medication Adherence in Kidney Transplant Patients
Status
Conditions
Treatments
Details and patient eligibility
About
Nonadherence to medication is a major obstacle to successful treatment of renal transplant patients. This study has two primary aims. The first is to test whether a culturally sensitive cognitive-behavioral adherence promotion program could significantly improve medication adherence to tacrolimus prescription. Participants will be randomly assigned to either group CBT or to standard care. The second aim is to pilot a novel strategy of adherence measurement - unannounced telephone pill counts, which has been shown to be a valid and reliable means to measure medication adherence in other patient populations. Participants will be recruited from waiting area of the kidney transplant clinic at SUNY Downstate Medical Center in Brooklyn, NY. Three unannounced telephone pill counts will be conducted prior to start of the intervention in order to establish baseline adherence and three pill counts will be conducted post-intervention. Tacrolimus trough concentration levels will also be collected as an additional biological measure of adherence.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- current prescription of tacrolimus less than 98% adherence to medication prescription as determined by three baseline pill counts
Exclusion criteria
- lack of telephone to complete pill counts lack of English proficiency to participate in adherence promotion sessions
Trial design
45 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal